AbbVie Vs. Sanofi: Which Is The Better Investment Right Now
Discover whether AbbVie or Sanofi holds the edge in the global immunology market and find out which stock shows more ...
Yahoo Finance26d
AbbVie (NYSE:ABBV) Urges Shareholders To Reject Proposals On Voting Rules And Human Rights Due Diligence
AbbVie is navigating significant shareholder activism as it urges opposition to two governance proposals ahead of its May 2025 meeting, fostering investor attention. Despite reporting a Q4 net ...
pharmaphorum2d
CHMP backs Novartis’ Fabhalta as first oral therapy for PNH
The March meeting of the EMA’s human medicines committee (CHMP) saw an approval recommendation for Novartis’ Fabhalta, on track to become the first oral monotherapy for rare disease paroxysmal ...
Investing18d
Abbvie Inc DRC (ABBVm)
AbbVie (NYSE:ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and ...
Reuters4d
US Supreme Court largely backs FDA's denial of flavored vape product applications
WASHINGTON, April 2 (Reuters) - The U.S. Supreme Court on Wednesday largely backed the U.S. Food and Drug Administration's refusal to let two e-cigarette companies sell flavored vape products that ...
CNN3d
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the ...
Monthly Prescribing Reference27d
February 2025: Notable Drug Approvals
Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) Meningococcal vaccine For active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y in ...
CNN22d
After canceling meeting of independent advisers, FDA issues 2025-26 flu vaccine recommendations
The FDA is recommending that flu vaccines for the 2025-26 season be trivalent, protecting against two strains of influenza A and one of influenza B.
Reuters27d
Kennedy asks FDA to revise 'self-affirm' rule for food ingredient safety
March 10 (Reuters) - U.S. Secretary of Health and Human Services Robert Kennedy Jr. directed the Food and Drug Administration on Monday to revise safety rules to help eliminate a provision that ...